Fetoscopic Tracheal Balloon Occlusion in Left Diaphragmatic Hernia
- Conditions
- Diaphragmatic Hernia
- Interventions
- Procedure: Fetoscopic tracheal balloon occlusion
- Registration Number
- NCT00373438
- Lead Sponsor
- University Hospital, Bonn
- Brief Summary
Left diaphragmatic hernia detected during fetal life carries a high risk for postnatal lung failure due to lung underdevelopment and pulmonary hypertension. In severe cases, extracorporeal membrane oxygenation (ECMO) is used as a life-saving intensive care means to enable survival of severely affected infants.
Clinical experience from prospective controlled non-randomized case series with fetoscopic tracheal balloon occlusion has seen improved survival rates in contrast to untreated controls.
Therefore, the purpose of this randomized clinical trial in a less severely affected subgroup of patients is whether by fetoscopic tracheal occlusion, the intensity of postnatal intensive care therapy might be reduced. Primary outcome measure is the need for postnatal ECMO therapy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 98
- Pregnant women from European countries carrying fetuses with left diaphragmatic hernia.
- Normal karyotype, no further severe anomalies on prenatal ultrasound study.
- Fetal liver herniation into the chest; gestational age-related lung volume between 20-25% of normal as determined by magnetic resonance imaging between 30+0 - 34+0 weeks+days of gestation.
- Any maternal disease or condition that would result in an increased risk to her health from the experimental procedure.
- Abnormal fetal karyotype, further severe fetal anomalies on prenatal ultrasound.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description A Fetoscopic tracheal balloon occlusion - B Fetoscopic tracheal balloon occlusion Fetoscopic tracheal occlusion
- Primary Outcome Measures
Name Time Method Need for postnatal ECMO therapy First two days of life
- Secondary Outcome Measures
Name Time Method Survival to discharge from hospital Days to discharge Maternal morbidity Until maternal discharge Fetal / Neonatal morbidity Overall & at discharge from hospital Premature preterm rupture of membranes Following the interventions over the remainder of gestation Unintended preterm delivery Following the interventions before scheduled elective delivery Days in intensive care Number of day until discharge from ICU Days in hospital Number of days until discharge from hospital Oxygen dependency on discharge Days until discharge
Trial Locations
- Locations (1)
German Center for Fetal Surgery & Minimally Invasive Therapy
🇩🇪Bonn, Germany